MAYNE PHARMA (Mayne Pharma International Pty Ltd)
Product name
MAYNE PHARMA
Date registered
Evaluation commenced
Decision date
Approval time
121 (255 working days)
Active ingredients
fluorouracil
Registration type
New generic medicine
Indication
Solar and senile keratoses, Bowen's disease.